[3612] Toledo, J. B., Arnold S. E., Raible K., Brettschneider J., Xie S. X., Grossman M., et al. (2013).  Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer’s Coordinating Centre. Brain. 136(9), 2697 - 2706.

[2849] Bomfim, T. R., Forny-Germano L., Sathler L. B., Brito-Moreira J., Houzel J-C., Decker H., et al. (2012).  An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease–associated Aβ oligomers. Journal of Clinical Investigation. 122(4), 1339 - 1353.

[2910] Talbot, K., Wang H-Y., Kazi H., Han L-Y., Bakshi K. P., Stucky A., et al. (2012).  Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. Journal of Clinical Investigation. 122(4), 1316 - 1338.

[2257] Naj, A. C., Jun G., Beecham G. W., Wang L-S., Vardarajan B. N., Buros J., et al. (2011).  Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet. 43(5), 436 - 441.

[1130] Wilson, R. S., Schneider J. A., Arnold S. E., Tang Y., Boyle P. A., & Bennett D. A. (2007).  Olfactory Identification and Incidence of Mild Cognitive Impairment in Older Age. Arch Gen Psychiatry. 64(7), 802 - 808.